Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
View ORCID ProfileDinesh Mohanraj, Samuel Baldwin, Satbeer Singh, Alun Gordon, View ORCID ProfileAlison Whitelegg
doi: https://doi.org/10.1101/2021.12.03.21267250
Dinesh Mohanraj
1Faculty of Medicine, Biology and Health, The University of Manchester, Manchester, UK
Samuel Baldwin
2Department of Blood Sciences, Portsmouth Hospital University NHS Trust, Portsmouth, UK
Satbeer Singh
2Department of Blood Sciences, Portsmouth Hospital University NHS Trust, Portsmouth, UK
Alun Gordon
2Department of Blood Sciences, Portsmouth Hospital University NHS Trust, Portsmouth, UK
Alison Whitelegg
3Department of Clinical Immunology, University Hospital Southampton NHS Trust, Southampton, UK
Data Availability
Data available upon request
Posted December 05, 2021.
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
Dinesh Mohanraj, Samuel Baldwin, Satbeer Singh, Alun Gordon, Alison Whitelegg
medRxiv 2021.12.03.21267250; doi: https://doi.org/10.1101/2021.12.03.21267250
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4364)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2813)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4130)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6719)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)